Status:

COMPLETED

A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole

Lead Sponsor:

Manhattan Eye, Ear & Throat Hospital

Collaborating Sponsors:

LuEsther T. Mertz Retinal Research Center

Conditions:

Chronic Central Serous Chorioretinopathy

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine the effect of an adrenocorticoid antagonist (ketoconazole), 600 mg per day for 4 weeks, in the treatment of patients with central serous chorioretinopathy (CS...

Detailed Description

A complete ophthalmic evaluation and tests: autofluorescence and Fluorescein angiography, Color Fundus Photography, OCT, including liver and adrenal functions and pregnancy test, if applicable will be...

Eligibility Criteria

Inclusion

  • Age less than 60 years
  • Must have clinical signs of CSC with leakage from the level of the RPE during fluorescein angiography and neurosensory detachment documented by optical coherence tomography (OCT).
  • Be able to return for all study visits for 3 months' duration.
  • Be able to provide written informed consent
  • Must have sufficiently clear media to allow for adequate fundus photography

Exclusion

  • Have choroidal neovascularization.
  • Have any evidence of clinically significant intraocular inflammation, angioid streaks, presumed ocular histoplasmosis syndrome, or other precursor of choroidal neovascularization.
  • Have additional eye disease that compromises the visual acuity of the study eye.
  • Are receiving any systemic steroid therapy
  • Have any significant medical history
  • Have a history of severe hypersensitivity reaction to any of the dyes or the drug used in the study.
  • Have any history of ocular conditions that may mimic CSC
  • Are pregnant

Key Trial Info

Start Date :

May 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2008

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT00211393

Start Date

May 1 2005

End Date

April 1 2008

Last Update

October 25 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Manhattan Eye, Ear & Throat Hospital

New York, New York, United States, 10021

A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole | DecenTrialz